Alcon Inc. ALC gains on strong market share gains. The company’s broad pipeline and focus on research and innovation are impressive. Yet, a challenging international market with geopolitical ...

Alcon is a global leader in IOLs and controls 40%-50% of the market, by our estimate. Its AcrySof IQ IOL, which was launched in 1994, is most implanted IOL in the world. It was the first IOL to be ...

The webcast can be accessed online through Alcon's Investor Relations website, i.e. investor.alcon.com. Listeners should log on approximately 10 minutes in advance. A replay will be available ...

Alcon Research LLC is trying to engineer a cheap acquisition of Aurion Biotech Inc. by blocking Aurion’s other funding options and improperly gaining influence on its board, Aurion investors claim in ...

As Alcon Research seeks to block investee Aurion Biotech from listing on the New York Stock Exchange, another investor has come to Aurion’s defense. Deerfield Management has sued Alcon Research ...